EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Beyond chromatin accessibility: bulk ATAC-seq as an integrative assay to portray genomes and epigenomes

Islem Toumi, Chaimae Kham, Lucille Stuani, Laurent Le Cam, Pierre-François Roux iD

NAR Genomics and Bioinformatics · 2026

DOI: 10.1093/nargab/lqag046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NAR Genomics and Bioinformatics, 2026. Verfasst von Islem Toumi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Univ. Montpellier, Institut régional du Cancer de Montpellier (ICM), 34298…. Hauptthemen laut MEDLINE: Chromatin, Epigenome, Epigenomics, Chromatin Immunoprecipitation Sequencing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ligue Contre le Cancer, ARC, Institut National contre le Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Assay for transposase-accessible chromatin using sequencing (ATAC-seq) is a cornerstone for epigenomic profiling, yet its potential for genomic characterization remains poorly explored. Here, we systematically benchmarked bulk ATAC-seq against whole-genome sequencing (WGS) to assess its capacity for detecting small variants, copy number variations (CNVs), telomere-associated repeat content, and mitochondrial single-nucleotide polymorphisms in cancer cells. Using paired datasets from patient-derived melanoma cell lines and from TCGA primary brain tumors, we demonstrated that ATAC-seq achieves high precision in small variants detection within accessible regions supporting cohort-scale genotyping and genetic stratification, robustly resolves CNVs in the nuclear genome, and supports high-coverage mitogenome profiling, with strong concordance to WGS at standard sequencing depths. Notably, we present the first systematic evaluation of telomere-associated repeat content by ATAC-seq, revealing its untapped potential for studying genome stability. By bridging genomic and epigenomic insights into a single genome-wide approach, bulk ATAC-seq emerges as a cost-effective and versatile tool poised to transform cancer research and to support integrative molecular profiling in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChromatinEpigenomeEpigenomicsChromatin Immunoprecipitation SequencingGenome, HumanHumansDNA Copy Number VariationsPolymorphism, Single NucleotideWhole Genome SequencingTransposasesCell Line, TumorBrain Neoplasms

Substanzen

ChromatinTransposases

Autor:innen und Institutionen

  • Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Univ. Montpellier, Institut régional du Cancer de Montpellier (ICM), 34298 Montpellier, France.
  • Equipe labélisée Ligue Contre le Cancer, 75013 Paris, France.

ORCID-Profile: Pierre-François Roux

Förderung

  • Ligue Contre le Cancer
  • ARC
  • Institut National contre le Cancer
  • Fondation pour la Recherche Médicale
  • Inserm

Zitieren

APA

Toumi, I., Kham, C., Stuani, L., Le Cam, L., & Roux, P. F. (2026). Beyond chromatin accessibility: bulk ATAC-seq as an integrative assay to portray genomes and epigenomes. NAR Genomics and Bioinformatics. https://doi.org/10.1093/nargab/lqag046

Vancouver

Toumi I, Kham C, Stuani L, Le Cam L, Roux PF. Beyond chromatin accessibility: bulk ATAC-seq as an integrative assay to portray genomes and epigenomes. NAR Genomics and Bioinformatics. 2026. doi:10.1093/nargab/lqag046

BibTeX
@article{Toumi2026,
  author = {Toumi, Islem and Kham, Chaimae and Stuani, Lucille and Le Cam, Laurent and Roux, Pierre-François},
  title = {Beyond chromatin accessibility: bulk ATAC-seq as an integrative assay to portray genomes and epigenomes},
  journal = {NAR Genomics and Bioinformatics},
  year = {2026},
  doi = {10.1093/nargab/lqag046}
}
Kostenlos starten →